Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2017 Jan 1;123(1):12-16.
doi: 10.1002/cncr.30266. Epub 2016 Oct 11.

The role of postoperative chemoradiation for oropharynx carcinoma: A critical appraisal revisited

Jay S Cooper  1 , Catherine Fortpied  2 , Vincent Gregoire  3 , Quynh-Thu Le  4 , Thomas F Pajak  5 , Qiang Ed Zhang  6 , Jacques Bernier  7
Affiliations
Comment

The role of postoperative chemoradiation for oropharynx carcinoma: A critical appraisal revisited

Jay S Cooper et al. Cancer. .

Abstract

A recent review in this Journal, which criticizes NCCN’s recommendations based, in part, on the RTOG 9501 and the EORTC 22931 trials, warrants comment. We herein provide additional data addressing many of the points and misinterpretations raised in that review which convincingly supports the use of concomitant chemotherapy and radiotherapy in patients with good performance status and high-risk pathologic features after surgery for mucosal head and neck squamous cell carcinoma.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest disclosures from any of the authors.

Figures

Figure 1
Figure 1
Comparison of local-regional control and survival rates for all patients grouped by primary tumor site (oropharynx vs. non-oropharynx) and treatment (RT vs. CERT).
Figure 2
Figure 2
Comparison of local-regional control and survival rates for patients who had extracapsular extension of disease and/or an involved surgical margin grouped by primary tumor site (oropharynx vs. non-oropharynx) and treatment (RT vs. CERT).
See this image and copyright information in PMC

Comment in

Comment on

References

    1. Sinha P, Piccirillo JF, Kallogjeri D, Spitznagel EL, Haughey BH. The role of postoperative chemoradiation for oropharynx carcinoma: a critical appraisal of the published literature and National Comprehensive Cancer Network guidelines. Cancer. 2015 Jun 1;121(11):1747–1754. - PubMed
    1. Cooper JS, Pajak TF, Forastiere AA, Jacobs J, Campbell BH, Saxman SB, Kish JA, Kim HE, Cmelak AJ, Rotman M, Machtay M, Ensley JF, Chao KSC, Schultz CJ, Lee N, Fu KK. Postoperative Concurrent Radiation Therapy and Chemotherapy in High-Risk Squamous Cell Carcinoma of the Head & Neck: The RTOG 9501/Intergroup Phase III Trial. N Engl J Med. 2004 May 6;350(19):1937–1944. - PubMed
    1. Bernier J, Domenge C, Ozsahin M, Matuszewska K, Lefèbvre JL, Greiner RH, Giralt J, Maingon P, Rolland F, Bolla M, Cognetti F, Bourhis J, Kirkpatrick A, van Glabbeke M. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J. Med. 2004 May 6;350(19):1945–1952. - PubMed
    1. Bernier J, Cooper JS, Pajak TF, van Glabbeke M, Bourhis J, Forastiere A, Ozsahin EM, Jacobs JR, Jassem J, Ang KK, Lefebvre JL. Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501) Head Neck. 2005;27(10):843–850. - PubMed
    1. Cooper JS, Zhang Q, Pajak TF, Forastiere AA, Jacobs J, Saxman SB, Kish JA, Kim HE, Cmelak AJ, Rotman M, Lustig R, Ensley JF, Thorstad W, Schultz CJ, Yom SS, Ang KK. Long-term Follow-up of the RTOG 9501/Intergroup Phase III Trial: Postoperative Concurrent Radiation Therapy and Chemotherapy in High-Risk Squamous Cell Carcinoma of the Head and Neck. Int J Radiat Oncol Biol Phys. 2012 Jun 30;84(5):1198–1205. - PMC - PubMed

Publication types

LinkOut - more resources